Elsevier

World Neurosurgery

Volume 80, Issues 3–4, September–October 2013, Pages 363-370
World Neurosurgery

Peer-Review Report
The Role of Nrf2 in Migration and Invasion of Human Glioma Cell U251

https://doi.org/10.1016/j.wneu.2011.06.063Get rights and content

Objective

NF-E2-related factor 2 (Nrf2) is a transcription factor that is related to tumor cell multidrug resistance and proliferation. Here we studied the involvement of Nrf2 in the migration and invasion of human U251 glioma cells.

Methods

Two kinds of plasmid, that is, pEGFP-Nrf2 and Si-Nrf2, were constructed and transfected to upregulate or downregulate the expression of Nrf2 in U251 glioma cell line. Blank vectors or random siRNA plasmid were used as negative control. Cells treated with lipofectamine only were set up as blank control. Protein and mRNA level of Nrf2 and matrix metalloproteinase 9 (MMP9) were investigated by reverse transcriptase–polymerase chain reaction and western blot after transfection. Wound healing assay and transwell assay were used to study migration and invasion of U251 after transfection. Gelatin zymography was performed to reveal the change of MMP9 activity after transfection.

Results

The mRNA and protein level of Nrf2 was upregulated in U251-pEGFP-Nrf2 while downregulated in U251-Si-Nrf2 48 hours after transfection. In the wound healing assay, there were more cells in group pEGFP-Nrf2 crossing the scratch line than in group Si-Nrf2. Furthermore, in transwell migration and invasion assay, there were more cells in group pEGFP-Nrf2 penetrating the membranes than in group Si-Nrf2. Then we investigated the change of MMP9 activity, mRNA, and protein levels after transfection. The results suggested that upregulation of Nrf2 led to an increase in MMP9 expression and activity whereas downregulation of Nrf2 led to a decrease in MMP9 expression and activity.

Conclusion

Nrf2 is involved in migration and invasion of U251 cells, which may be related to MMP9.

Introduction

The transcription factor NF-E2-related factor 2 (Nrf2) is considered as a critical regulator of intracellular antioxidants and phase II detoxification enzymes by transcriptional upregulation of many antioxidant response element (ARE)-containing genes. It belongs to Keap1-Nrf2-ARE signaling pathway. In response to oxidative stress, Nrf2 is activated and dissociated from Keap1. After translocated from cytoplasm to nucleus, Nrf2 forms a heterodimer with Maf, which binds to the ARE sequence to upregulate many kinds of genes expression (21). The Nrf2 downstream genes include 1) intracellular redox-balancing proteins: glutamate cysteine ligase, glutathione peroxidase, and heme oxygenase-1; 2) phase II detoxifying >enzymes: glutathione S-transferase (GST) and NAD(P)H quinone oxidoreductase–1; and 3) transporters: multidrug resistance–associated protein (21). Recent studies have found more Nrf2 downstream genes that are involved in stress response, xenobiotics metabolism, the ubiquitin-mediated proteasomal degradation system, cell proliferation and so on (5, 20, 22, 36, 41). In normal tissue, Nrf2 is considered as an important transcript factor for cells to survive from many kinds of negative stimulus such as injury, ischemia, inflammation, hemorrhage, cancer, pulmonary fibrosis, acute pulmonary injury, and degeneration disease (6, 8, 18, 19, 36, 38, 42, 44). Interestingly, Nrf2 may play a dark role in tumor tissue. It has been verified that Nrf2 is upregulated in lung, head, and neck squamous cell carcinoma tissues (39, 40). Further investigation shows that overexpression of Nrf2 enhances tumor resistance to chemotherapeutic agents in some lung carcinoma, breast adenocarcinoma, and neuroblastoma cell lines (43).

Matrix metalloproteinase 9 (MMP9), which belongs to the ECM-degrading enzyme family, is a kind of gelatinase. MMP9 is involved in migration and invasion of tumor cells. It has been found that the transcription and activity levels of MMP9 are higher in glioma than in normal brain and such elevation is strongly correlated with the tumor grade (9). Our previous study (25) proved that MMP9 was upregulated in Nrf2 knockout mice than wild-type mice after spinal cord injury. This result suggests the possible relationship between Nrf2 and MMP9. In this study, we investigated the change of MMP9 level, migration, and invasion ability of human U251 glioma cells after up- or downregulating the expression of Nrf2.

Section snippets

Cell Culture and Transient Transfection

Human U251 glioma cells were obtained from ATCC and cultured in Dulbecco's modified Eagle medium (DMEM; HyClone, Illinois, USA) with 10% fetal bovine serum (HyClone) at 37°C and 5% CO2 incubator. The primers for human Nrf2 cDNA were as follows: forward 5′-CCGCTCGAGATGATGGACTTGGAGCTGCC-3′, reverse 5′-GGGGTACCGTGTTTTTCTTAACATCTGGC-3′. Human Nrf2 cDNA was cloned into the cloning site of the vector pEGFP-N1 (GeneChem, Shanghai, China) using the standard recombinant DNA technique. The new plasmid

Transient Transfection Effect on Nrf2 mRNA and Protein Level

To validate the transient transfection effect of four plasmids mentioned above, we tested the mRNA and protein level of five cell groups 24, 48, 72 hours after transfection, respectively. RT-PCR and western blot results indicated that transfection efficiency was most predominant at 48 hours after transfection (data not shown). Transfection of pEGFP-Nrf2 enhanced the Nrf2 mRNA and protein level >38% and >130% as compared with transfection of pEGFP, respectively (P < 0.05). Si-Nrf2 transfection

Discussion

Nrf2 was first discovered by Moi in 1994 (27). Follow-up study showed that Nrf2 is a critical transcription factor in Keap1-Nrf2-ARE signaling pathway to resist oxidative stress. Nrf2 is considered as a “good” protein because many chemopreventive compounds have been found to be its inducer, such as sulforaphane (16), curcumin (1), epigallocatechin-3-gallate (29), resveratrol (4), wasabi (28), cafestol, kahweol (12), lycopene (3), and carnosol (37). All these compounds have been proven to be

References (45)

  • D. Meng et al.

    Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism

    Toxicol Appl Pharmacol

    (2010)
  • Y. Morimitsu et al.

    A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway

    J Biol Chem

    (2002)
  • H.K. Na et al.

    Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG

    Food Chem Toxicol

    (2008)
  • P. Nioi et al.

    A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity

    Biochem Biophys Res Commun

    (2007)
  • J. Pi et al.

    Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2

    Free Radic Biol Med

    (2008)
  • J. Wang et al.

    Role of Nrf2 in protection against intracerebral hemorrhage injury in mice

    Free Radic Biol Med

    (2007)
  • E. Balogun et al.

    Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

    Biochem J

    (2003)
  • L. Becks et al.

    Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene

    BMC Cancer

    (2010)
  • A. Ben-Dor et al.

    Carotenoids activate the antioxidant response element transcription system

    Mol Cancer Ther

    (2005)
  • H.Y. Cho et al.

    Nrf2 defends the lung from oxidative stress

    Antioxid Redox Signal

    (2006)
  • H.Y. Cho et al.

    The transcription factor NRF2 protects against pulmonary fibrosis

    FASEB J

    (2004)
  • A.T. Dinkova-Kostova et al.

    Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

    Proc Natl Acad Sci U S A

    (2005)
  • Cited by (0)

    Conflict of interest statement: Supported by grants from National Natural Science Foundation of China (No. 81070974), the Jiangsu Provincial Key Subject (X4200722), and Jinling Hospital of Nanjing, China (2010Q017).

    View full text